CONTROL OF THE MENSTRUAL CYCLE: A NEW CONCEPT OF THE USE OF COMBINED ORAL CONTRACEPTIVES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To carry out a systematic review of the studies assessing women’s attitude to hormonal contraceptives, a prolonged dosage regimen, and the problem of missing the pills. Material and methods. The review includes the data of foreign and Russian papers published in the past 40 years and found in the Pubmed. Results. The given data prove the safety and efficiency of a prolonged contraceptive regimen especially when an electronic dispenser with reminding function is used. This contraceptive method improves adherence and allows women to control their menstrual cycle. Conclusion. Currently available hormonal contraceptives give women the chance to control their menstrual cycle. Innovations in hormonal contraception help women take hormonal pills correctly.

Full Text

Restricted Access

About the authors

Irina V. Kuznetsova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: ms.smith.ivk@gmail.com
MD, PhD, main researcher, Women’s Health Research Center Moscow 119991, Trubetskaya str. 8, bld. 2, Russia

Denis I. Burchakov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: dr.burchakov@yandex.ru
researcher of Women’s Health Research Center Moscow 119991, Trubetskaya str. 8, bld. 2, Russia

References

  1. Denisov B.P., Sakevich V.I., Jasilioniene A. Divergent trends in abortion and birth control practices in belarus, Russia and Ukraine. PLoS One. 2012; 7(11): e49986.
  2. Thomas S.L., Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet. 2000; 355(9207): 922-4.
  3. Loudon N.B., Foxwell M., Potts D.M., Short R.V., Guild A.L., Short R.V. Acceptability of an oral contraceptive that reduces the frequency of menstruation : the tri-cycle pill regimen. Br. Med. J. 1977; 2(6085): 487-90.
  4. Cachrimanidou A., Hellberg D., Nilsson S., Waldenstrom U., Olsson S., Sikstrom B. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1993; 48(3): 205-16.
  5. Archer D.F., Jensen J.T., Johnson J.V., Borisute H., Grubb G.S., Constantine G.D. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception. 2006; 74(6): 439-45.
  6. Sulak P.J., Scow R.D., Preece C., Riggs M.W., Kuehl T.J. Hormone withdrawal symptoms in oral contraceptive users. Obstet. Gynecol. 2000; 95(2): 261-6.
  7. Read C.M. New regimens with combined oral contraceptive pills--moving away from traditional 21/7 cycles. Eur. J. Contracept. Reprod. Health Care. 2010; 15 (Suppl. 2): S32-41.
  8. Benagiano G., Carrara S., Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Prefer Adherence. 2009; 3: 131-43.
  9. Dawood M.Y. Primary dysmenorrhea: advances in pathogenesis and management. Obstet. Gynecol. 2006; 108(2): 428-41.
  10. Schneider M.B., Fisher M., Friedman S.B., Bijur P.E., Toffler A.P. Menstrual and premenstrual issues in female military cadets: a unique population with significant concerns. J. Pediatr. Adolesc. Gynecol. 1999; 12(4): 195-201.
  11. Lee K.A., Zaffke M.E., Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J. Womens Health Gend. Based Med. 2001; 10(4): 335-41.
  12. Szarewski A., von Stenglin A., Rybowski S. Women’s attitudes towards monthly bleeding: results of a global population-based survey. Eur. J. Contracept. Reprod. Health Care. 2012; 17(4): 270-83.
  13. Andrist L.C., Arias R.D., Nucatola D., Kaunitz A.M., Musselman B.L., Reiter S. et al. Women’ s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004; 70(5): 359-63.
  14. Wiegratz I., Hommel H.H., Zimmermann T., Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004; 69(1): 37-42.
  15. Szarewski A., Moeller C. Women’s perceptions about reducing the frequency of monthly bleeding results from a multinational survey. Open Access J. Contracept. 2013; 4: 29-37.
  16. Wiegratz I., Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004; 64(21): 2447-62.
  17. Ferrero S., Abbamonte L.H., Giordano M., Alessandri F., Anserini P., Remorgida V. et al. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception. 2006; 73(5): 537-41.
  18. Glasier A.F., Smith K.B., van der Spuy Z.M., Ho P.C., Cheng L., Dada K. et al. Amenorrhea associated with contraception-an international study on acceptability. Contraception. 2003; 67(1): 1-8.
  19. Rutter W., Knight C., Vizzard J., Mira M., Abraham S. Women’s attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med. J. Aust. 1988; 149(8): 417-9.
  20. den Tonkelaar I., Oddens B.J. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999; 59(6): 357-62.
  21. Miller L., Notter K.M. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet. Gynecol. 2001; 98(5, Pt 1): 771-8.
  22. Edelman A., Micks E., Gallo M.F., Jensen J.T., Grimes D.A. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst. Rev. 2014; (7): CD004695.
  23. Cintron D., Lipford M., Spencer-Bonilla G., Lloyd R., Gionfriddo M.R., Gunjal S. et al. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine. 2016; Aug 11.
  24. Kwiecien M., Edelman A., Nichols M.D., Jensen J.T. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003; 67(1): 9-13.
  25. Legro R.S., Pauli J.G., Kunselman A.R., Meadows J.W., Kesner J.S., Zaino R.J. et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2008; 93(2): 420-9.
  26. Anderson F.D., Gibbons W., Portman D. Safety and efficacy of an extendedregimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception. 2006; 73(3): 229-34.
  27. Kroll R., Reape K.Z., Margolis M. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol. Contraception. 2010; 81(1): 41-8.
  28. Lete I., Doval J.L., Pérez-Campos E., Lertxundi R., Correa M., de la Viuda E. et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception. 2008; 77(4): 276-82.
  29. Aubeny E., Buhler M., Colau J.C., Vicaut E., Zadikian M., Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur. J. Contracept. Reprod. Health Care. 2002; 7(3): 155-61.
  30. Potter L., Oakley D., de Leon-Wong E., Canamar R. Measuring compliance among oral contraceptive users. Fam. Plann. Perspect. 1996; 28(4): 154-8.
  31. Hou M.Y., Hurwitz S., Kavanagh E., Fortin J., Goldberg A.B. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet. Gynecol. 2010; 116(3): 633-40.
  32. Sedgh G., Singh S., Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud. Fam. Plann. 2014; 45(3): 301-14.
  33. Rosenberg M.J., Waugh M.S., Meehan T.E. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995; 51(5): 283-8.
  34. Zapata L.B., Steenland M.W., Brahmi D., Marchbanks P.A., Curtis K.M. Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review. Contraception. 2013; 87(5): 685-700.
  35. Elliesen J., Trummer D. Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studies. Int. J. Womens Health. 2016; 8: 351-6.
  36. Nappi R.E., Kaunitz A.M., Bitzer J. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians. Eur. J. Contracept. Reprod. Health Care. 2016; 21(2): 106-15.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies